First milestone payment for ADC-1013
Alligator Bioscience AB is a privately held Swedish biotech company developing immuno-oncology antibodies for directed immunotherapy of canc ...
Alligator Bioscience Announces Collaboration with Johnson & Johnson Innovation for the CD40 Agonistic Immuno-Oncology Antibody ADC-1013
Alligator Bioscience AB, a privately held Swedish biotech company developing immuno-oncology antibodies for directed immunotherapy of cancer ...
Alligator Bioscience Starts a Clinical Phase 1 Multicenter Trial
Alligator Bioscience Starts a Clinical Phase 1 Multicenter Trial in Advanced Solid Tumors with the CD40 Agonistic Immuno-Oncology Antibody A ...